bioAffinity signs distribution agreement with AvMEDICAL
bioAffinity Technologies has entered into a nationwide distribution agreement with AvMEDICAL to market CyPath Lung to federal healthcare agencies, including the VA, thereby expanding commercial reach.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day